Latest Period
n/a
Security Snapshot
AVENUE THERAPEUTICS, INC. - Common Stock (ATXI) Institutional Ownership
CUSIP: 05360L403
13F Institutional Holders and Ownership History from Q2 2024 to Q1 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.66
Save this security research path
Keep this CUSIP in your research flow, then return after the next filing cycle to check what changed.
- Type / Class
- Equity / Common Stock
- Symbol
- ATXI on OTC
- Shares outstanding
- 3,190,732
- Price per share
- $0.66
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ATXI - AVENUE THERAPEUTICS, INC. - Common Stock is tracked under CUSIP 05360L403.
- Latest finished 13F holder period is not available.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 7 to 0 between Q4 2024 and Q1 2025.
- Reported value moved from $385,256 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Schedule 13D/13G
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 05360L403?
CUSIP 05360L403 identifies ATXI - AVENUE THERAPEUTICS, INC. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 05360L403:
Significant Owners of AVENUE THERAPEUTICS, INC. - Common Stock (ATXI) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 13% | +31% | $290,370 | +$73,398 | 439,955 | +34% | Fortress Biotech, Inc. | 02 Jan 2026 |
| Ikarian Capital, LLC | 4.1% | -39% | $86,341 | -$6,059 | 130,820 | -6.6% | Ikarian Capital, LLC | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC | 5% | $25,100 | 100,400 | Armistice Capital, LLC | 31 Dec 2024 |